TFF Pharmaceuticals, Inc.
TFFP · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $12,584 | $31,479 | $220,162 | $292,488 |
| - Cash | $5,478 | $16,612 | $33,795 | $35,301 |
| + Debt | $115 | $191 | $0 | $0 |
| Enterprise Value | $7,221 | $15,057 | $186,367 | $257,187 |
| Revenue | $734 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $231 | -$388 | -$111 | $0 |
| % Margin | 31.5% | – | – | – |
| EBITDA | -$20,741 | -$31,409 | -$30,927 | -$18,694 |
| % Margin | -2,826.2% | – | – | – |
| Net Income | -$21,243 | -$31,770 | -$30,987 | -$18,441 |
| % Margin | -2,894.7% | – | – | – |
| EPS Diluted | -11.85 | -26.49 | -31.21 | -22.57 |
| % Growth | 55.3% | 15.1% | -38.3% | – |
| Operating Cash Flow | -$16,038 | -$27,342 | -$29,557 | -$16,616 |
| Capital Expenditures | -$95 | -$1,551 | -$869 | -$1,103 |
| Free Cash Flow | -$16,133 | -$28,893 | -$30,425 | -$17,718 |